Literature DB >> 2994702

The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects.

J F Giudicelli, A Berdeaux, A Edouard, C Richer, D Jacolot.   

Abstract

The effects of enalapril, 20 mg orally, on the responses to baroreflex activation and deactivation by respectively phenylephrine and nitroglycerin were investigated in normotensive subjects on a normal sodium diet, with simultaneous measurement of plasma renin activity (PRA), converting enzyme activity (PCEA), aldosterone and catecholamines. Enalapril, 4 h after administration, lowered artificial blood pressure without modifying heart rate and plasma catecholamines. PCEA was abolished, PRA increased and plasma aldosterone decreased. Enalapril (a) displaced to the left the baroreflex set-point, (b) did not affect baroreflex sensitivity since the slopes of the RR-interval/systolic blood pressure regression lines remained unchanged during both activation and deactivation and (c) did not modify baroreflex efficacy since the maximal RR-interval responses as well as the overall RR-interval-time products to identical blood pressure variations were not modified. Thus, enalapril induced a resetting of the baroreflex, which probably accounts for the lack of reflex tachycardia observed during the drug-induced fall in blood pressure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994702      PMCID: PMC1400702          DOI: 10.1111/j.1365-2125.1985.tb05063.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  28 in total

1.  Haemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in hypertensive patients.

Authors:  R J Cody; R C Tarazi; E L Bravo; F M Fouad
Journal:  Clin Sci Mol Med       Date:  1978-11

2.  Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung.

Authors:  D W Cushman; H S Cheung
Journal:  Biochem Pharmacol       Date:  1971-07       Impact factor: 5.858

3.  Diminished baroreflex sensitivity in high blood pressure.

Authors:  J D Bristow; A J Honour; G W Pickering; P Sleight; H S Smyth
Journal:  Circulation       Date:  1969-01       Impact factor: 29.690

4.  A direct determination of plasma aldosterone.

Authors:  M T Pham-Huu-Trung; P Corvol
Journal:  Steroids       Date:  1974-11       Impact factor: 2.668

5.  Physiological and pharmacological characterization of the area postrema pressor pathways in the normal dog.

Authors:  C M Ferrario; K L Barnes; J E Szilagyi; K B Brosnihan
Journal:  Hypertension       Date:  1979 May-Jun       Impact factor: 10.190

6.  The role of arterial baroreceptors in the regulation of arterial pressure in conscious dogs.

Authors:  R J McRitchie; S F Vatner; G R Heyndrickx; E Braunwald
Journal:  Circ Res       Date:  1976-11       Impact factor: 17.367

7.  Determinants of baroreflex sensitivity in man.

Authors:  O Randall; M Esler; B Culp; S Julius; A Zweifler
Journal:  J Lab Clin Med       Date:  1978-03

8.  Attenuation by SQ 14,255 (captopril) of the vascular response to noradrenaline in the rate isolated kidney.

Authors:  D Casellas; A Mimran; M Dupont; C Chevillard
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

9.  Nonlinearities of the human carotid baroreceptor-cardiac reflex.

Authors:  D L Eckberg
Journal:  Circ Res       Date:  1980-08       Impact factor: 17.367

10.  Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.

Authors:  G A MacGregor; N D Markandu; J Bayliss; J E Roulston; M Squires; J J Morton
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-08
View more
  19 in total

1.  A clinical pharmacological assessment of doxazosin and enalapril in combination.

Authors:  A D Bainbridge; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

Review 2.  Cardiac effects of angiotensin converting enzyme inhibitors.

Authors:  N Sharpe
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

3.  Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.

Authors:  K M Yee; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

4.  The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects.

Authors:  A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

5.  Enalapril and baroreflex function in normotensive subjects.

Authors:  J F Giudicelli; A Berdeaux
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

Review 6.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

7.  Effect of captopril on changes in plasma noradrenaline induced by sodium nitroprusside.

Authors:  R H Becker; A D Struthers; M J Brown
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

8.  Effect of fentanyl on heart rate variability during mechanical ventilation.

Authors:  Kei Kohno; Junken Koh; Yoshihiro Kosaka
Journal:  J Anesth       Date:  1997-12       Impact factor: 2.078

9.  Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine.

Authors:  M Bellet; P Sassano; T Guyenne; P Corvol; J Menard
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

10.  A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig.

Authors:  M Rechtman; H Majewski
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.